CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2320 in AML
CompanyDrug

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2320 in AML

Danaher Partners with Huashan Hospital to Develop Alzheimer's Diagnostic Solutions
CompanyDeals

Danaher Partners with Huashan Hospital to Develop Alzheimer’s Diagnostic Solutions

Chongqing Genrix's Xeligekimab Approved for Ankylosing Spondylitis by NMPA
CompanyDrug

Chongqing Genrix’s Xeligekimab Approved for Ankylosing Spondylitis by NMPA

Takeda to Establish China Innovation Center in Chengdu, Focusing on Digital Health
CompanyDeals

Takeda to Establish China Innovation Center in Chengdu, Focusing on Digital Health

NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status
Policy / Regulatory

NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status

FDA Approves AstraZeneca's Calquence for Mantle Cell Lymphoma
CompanyDrug

FDA Approves AstraZeneca’s Calquence for Mantle Cell Lymphoma

NAMSA to Acquire WuXi AppTec's US Medical Device Testing Business
CompanyDeals

NAMSA to Acquire WuXi AppTec’s US Medical Device Testing Business

MHRA Approves Gilead's Livdelzi for Primary Biliary Cholangitis
CompanyDrug

MHRA Approves Gilead’s Livdelzi for Primary Biliary Cholangitis

Tianjin Healthcare Official Gao Xue Under Investigation
Policy / Regulatory

Tianjin Healthcare Official Gao Xue Under Investigation

US BIS Imposes Export Controls on Biotech Lab Instruments
Medical DevicePolicy / Regulatory

US BIS Imposes Export Controls on Biotech Lab Instruments

Junshi Biosciences Forecasts 29.71% Revenue Growth for 2024
Company

Junshi Biosciences Forecasts 29.71% Revenue Growth for 2024

FDA Clears Amgen's Lumakras and Vectibix Combo for KRAS G12C-mutated mCRC
CompanyDrug

FDA Clears Amgen’s Lumakras and Vectibix Combo for KRAS G12C-mutated mCRC